Pratiksha Chemicals June 2026: Trading Window Closes
Ask Iris
What the company has announced
Pratiksha Chemicals Ltd has announced the closure of its trading window for all designated persons, including directors and promoters, and their relatives. The closure is effective from July 01, 2026. It will remain closed until 48 hours after the declaration of the company’s unaudited financial results for the quarter ended June 30, 2026. Trading-window closures are typically used to restrict dealing in company securities when unpublished price sensitive information may exist. The update is relevant for investors tracking near-term disclosures and compliance actions. It also signals that the company is preparing to publish results for the June 2026 quarter.
Who is covered under the trading window restrictions
The company’s communication states that the restriction applies to “designated persons,” which includes directors and promoters, and also extends to their relatives. In practice, this category generally covers individuals who may have access to financial information ahead of results publication. The trading window mechanism is commonly applied around financial reporting dates to reduce the risk of insider trading. The company did not provide a specific date for the results announcement in the provided text. It only specified that the window will reopen 48 hours after the unaudited results for the quarter ended June 30, 2026 are declared. Investors should read this as a compliance calendar marker rather than a financial performance indicator by itself.
Board actions on audited results for March 2026
Separately, Pratiksha Chemicals stated that its board approved the audited financial results for the quarter and year ended March 31, 2026. The approval was recorded as having taken place in a meeting held on May 14, 2026. The audit report was issued by M/S Chandabhoy & Jassoobhoy, Chartered Accountants, and carried an unmodified opinion on the standalone financial results. The text also notes that the auditor raised concerns regarding gratuity and leave encashment accounting. An unmodified opinion typically indicates the auditor did not find material misstatements requiring qualification, although attention points can still be disclosed.
Another board meeting reference and earlier trading-window closure
The company also announced that a meeting of the Board of Directors was scheduled for May 14, 2026 to consider and approve the unaudited financial results for the quarter ended March 31, 2026. Alongside that, it said the trading window for dealing in the company’s securities had been closed since April 1, 2026. The same communication stated the window would remain closed until 48 hours after the results were submitted. This indicates the company used similar trading-window controls around the March 2026 quarter reporting process. Such notices are typically shared through stock exchange filings to ensure uniform disclosure. The multiple references in the provided text show a sequence of compliance steps around result approvals and disclosures.
March 2026 quarter: profit turns positive YoY
For the quarter ended March 2026, Pratiksha Chemicals reported net profit of ₹0.21 crore. This compared with a net loss of ₹1.96 crore in the previous quarter ended March 2025, as stated in the text. Sales rose 151.06% to ₹1.18 crore in the quarter ended March 2026 from ₹0.47 crore in the quarter ended March 2025. In another standalone quarterly snapshot within the provided content, EBITDA for March 2026 is shown at ₹0.70 crore versus ₹-4.50 crore in March 2025. The same snapshot notes EPS increased to ₹0.38 in March 2026 from ₹-3.52 in March 2025. These numbers indicate a year-on-year improvement in both operating and net profitability for the March 2026 quarter, based on the disclosures shared.
Full-year FY2026: net profit reported at ₹4.99 crore
For the full year ended March 2026, the company reported net profit of ₹4.99 crore. This compares with a net loss of ₹7.66 crore during the previous year ended March 2025, as per the text. However, sales declined 22.94% to ₹4.67 crore in the year ended March 2026 from ₹6.06 crore in the year ended March 2025. The combination of lower annual sales but improved net profit suggests that other elements in the reported numbers may have shifted meaningfully year-on-year, though the provided text does not detail drivers. Investors typically look for additional line-item disclosures to reconcile such changes. The company’s audited standalone results and related notes are therefore important context for interpreting the year’s performance.
Other quarterly data points mentioned in the text
The provided content also includes a set of quarterly references that are presented as Q4 FY2026 standalone versus Q3 FY2026. In that comparison, revenue is shown at ₹1.29 crore (up 469.9%), expenditure at ₹0.93 crore (up 2017.5%), and net profit at ₹0.01 crore (down 93.0%). Operating profit margin (OPM) is shown at 13.61%, down 4.51 percentage points. Another set of figures lists Q2 FY2026 revenue at ₹2.18 crore (up 86.3%) and net profit at ₹6.60 crore (up 412.4%) with OPM at 100.00%, and Q1 FY2026 revenue at ₹1.17 crore (up 131.1%) and net profit at ₹-2.11 crore. These figures are reported as provided, without additional reconciliation in the text.
Unaudited December 2025 quarter numbers cited
One section of the content refers to “Unaudited Financial Results For The Quarter Ended On December 31 2025” dated February 5, 2026. It states revenue stood at ₹4.69 crore, a quarter-on-quarter increase of 86.85% from ₹2.51 crore. Operating profit is stated at ₹0.04 crore. PBDT is stated at ₹0.07 crore, while profit before tax is stated at ₹-0.17 crore and net profit at ₹-0.14 crore. These numbers, as stated, show a quarter where reported revenue increased sequentially while profit after tax remained negative. Such data points often matter when investors compare operational momentum versus bottom-line outcomes.
Stock price and market data points provided
The text notes that Pratiksha Chem shares closed at 18.83 on May 13, 2026 (BSE). It also states the stock delivered -0.89% returns over the last 6 months and 4.44% over the last 12 months, as per that same snapshot. Separately, another data block states the share price was ₹26.80 as of 2026-02-19 and market capitalisation was ₹14.15 as of 2026-02-18. The 52-week high and low are listed as ₹27.75 and ₹15.88, respectively, as of 2026-02-19. These datapoints are time-stamped and should be read in the context of the stated dates.
Key facts table
Timeline of notices and reporting steps
Registered office details included in the disclosure
The company’s registered office address is stated as H K Complex, 3rd Floor, Opp. Dharnidhar Derasar, Vasna, Ahmedabad, Gujarat, Pin Code 380007. Another address line in the text lists “3rd Floor H K Complex, Nr Dharnidhar Temple Vasna, Ahmedabad, Gujarat-380007” with phone numbers. These details are typically included in filings and published result communications. For shareholders and other stakeholders, such information helps verify corporate identity and correspondence details.
Why this matters for investors
Trading-window closures are a compliance signal that financial results are being prepared and information flow is being controlled internally. For Pratiksha Chemicals, the July 2026 closure sets the near-term focus on the unaudited results for the quarter ended June 30, 2026. The company has also recently reported a positive net profit of ₹0.21 crore for the March 2026 quarter and a full-year net profit of ₹4.99 crore for FY2026, while annual sales were reported lower at ₹4.67 crore. Market datapoints provided in the text show differing share price readings across dates, including a close of 18.83 (BSE) on May 13, 2026 and a quoted price of ₹26.80 as of February 19, 2026. Investors following the stock may track the next results release to see whether quarterly revenue and profitability trends remain consistent with the numbers already disclosed.
Conclusion
Pratiksha Chemicals’ latest filing highlights a trading-window closure starting July 01, 2026, linked to the upcoming unaudited results for the quarter ended June 30, 2026. The company has also completed board approvals and an audit process for the quarter and year ended March 31, 2026, with an unmodified audit opinion and certain accounting concerns flagged around employee benefits. The next concrete milestone is the declaration of the June 2026 quarter results, after which the trading window is expected to reopen 48 hours later, as stated in the company’s notice.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
